Overview
Escherichia coli meningitis is a severe form of bacterial meningitis caused by specific strains of E. coli, often involving neonatal and immunocompromised populations. It requires prompt diagnosis and aggressive management to prevent significant morbidity and mortality 3.Diagnosis
Clinical Presentation: Fever, irritability, poor feeding, lethargy, and signs of meningeal irritation 3.
Laboratory Tests: Cerebrospinal fluid (CSF) analysis showing neutrophilic pleocytosis, elevated protein, and low glucose levels 3.
Microbiological Confirmation: CSF culture is essential for definitive diagnosis, identifying E. coli as the causative agent 3.
Imaging: Lumbar puncture and possibly cranial imaging to rule out complications like hydrocephalus 3.Management
Antibiotics: Initial empirical therapy with third-generation cephalosporins (e.g., ceftriaxone) is recommended, followed by targeted therapy based on susceptibility testing 3.
Supportive Care: Close monitoring of intracranial pressure, fluid management, and management of seizures 3.
Adjunctive Therapies: Corticosteroids may be considered to reduce inflammation and improve outcomes, particularly in neonates 3.Special Populations
Neonates: Higher susceptibility; early recognition and aggressive antibiotic therapy are critical 3.
Immunocompromised Patients: Increased risk of complications; tailored antibiotic regimens based on immune status and CSF culture results are essential 3.Key Recommendations
Initiate Prompt Empiric Antibiotic Therapy: Use third-generation cephalosporins for suspected E. coli meningitis 3 (Evidence: Strong).
Perform CSF Culture and Sensitivity Testing: To guide targeted antibiotic therapy 3 (Evidence: Strong).
Consider Corticosteroids in Neonates: To mitigate inflammation and improve neurological outcomes 3 (Evidence: Moderate).References
1 Crechet JB, Canceill D, Bocchini V, Parmeggiani A. Characterization of the elongation factors from calf brain. 1. Purification, molecular and immunological properties. European journal of biochemistry 1986. link
2 Szewczuk A, Kuropatwa M, Prusak E, Wieczorek J. Two immunologically different penicillin amidases synthetized by Escherichia coli PCM 271. Archivum immunologiae et therapiae experimentalis 1984. link
3 Stöffler G, Wittmann HG. Sequence differences of Escherichia coli 30S ribosomal proteins as determined by immunochemical methods. Proceedings of the National Academy of Sciences of the United States of America 1971. link